Michael LeBlanc

Michael LeBlanc, PhD, serves as Professor in the Biostatistics Program of the Public Health Sciences Division at Fred Hutchinson Cancer Center (Fred Hutch) and holds a dual appointment as Research Professor in the Department of Biostatistics at the University of Washington. He directs the Statistics and Data Management Center for the SWOG Cancer Research Network, overseeing approximately 100 active clinical trials across design, accrual, and analysis phases, and is a member of Fred Hutch's Translational Data Science Integrated Research Center (TDS IRC).

His academic background includes a PhD in Biostatistics from the University of Washington (1989), an MMath in Statistics from the University of Waterloo (1984), and a BSc in Mathematics from Simon Fraser University (1983).

Dr. LeBlanc specializes in innovative clinical trial methodologies with expertise in adaptive regression techniques including tree-based and Boolean logic regression for subgroup identification. His research focuses on integrating biomarker and genetic data into trial frameworks, developing methods for long-term treatment efficacy assessment, and optimizing pragmatic trial designs with streamlined data collection. Current projects emphasize statistical approaches for trials involving immunocompromised populations and herpes treatment research.

As Group Statistician for SWOG, he leads statistical coordination for national cancer clinical trials and contributes to translational data science initiatives through the TDS IRC. His work bridges methodological innovation with practical applications in oncology research, as highlighted in recent features including a 2024 news release on improving clinical trials for immunocompromised patients.